They can't resist until they have some cash. Given all the lawsuits, the breeze hole in the bucket effect and marooned interest in Advent, you shouldn't hold your breath.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025